Trump’s FDA Cuts Are Putting Drug Development at Risk
-
New SEC filings from pharmaceutical companies reveal Donald Trump and Elon
Musk’s cost-cutting measures could slow drug research and delay FDA
approvals.
6 hours ago
No comments:
Post a Comment